U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Name Type Language
TANEZUMAB
INN   USAN   WHO-DD  
USAN   INN  
Official Name English
TANEZUMAB [USAN]
Common Name English
Tanezumab [WHO-DD]
Common Name English
RN-624
Code English
RN624
Code English
TANEZUMAB [JAN]
Common Name English
tanezumab [INN]
Common Name English
IMMUNOGLOBULIN G2, ANTI (HUMAN NERVE GROWTH FACTOR) (HUMAN MOUSE MONOCLONAL RN624 HEAVY CHAIN), DISULFIDE WITH HUMAN MOUSE MONOCLONAL RN624 LIGHT CHAIN, DIMER
Common Name English
PF-4383119
Code English
IMMUNOGLOBULIN G2, ANTI (HUMAN NERVE GROWTH FACTOR) (HUMAN MOUSE MONOCLONAL RN624 HEAVY CHAIN), DISULPHIDE WITH HUMAN MOUSE MONOCLONAL RN624 LIGHT CHAIN, DIMER
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C20401
Created by admin on Sat Dec 16 16:20:01 GMT 2023 , Edited by admin on Sat Dec 16 16:20:01 GMT 2023
Code System Code Type Description
INN
8941
Created by admin on Sat Dec 16 16:20:01 GMT 2023 , Edited by admin on Sat Dec 16 16:20:01 GMT 2023
PRIMARY
ChEMBL
CHEMBL2108567
Created by admin on Sat Dec 16 16:20:01 GMT 2023 , Edited by admin on Sat Dec 16 16:20:01 GMT 2023
PRIMARY
NCI_THESAURUS
C71522
Created by admin on Sat Dec 16 16:20:01 GMT 2023 , Edited by admin on Sat Dec 16 16:20:01 GMT 2023
PRIMARY
CAS
880266-57-9
Created by admin on Sat Dec 16 16:20:01 GMT 2023 , Edited by admin on Sat Dec 16 16:20:01 GMT 2023
PRIMARY
USAN
SS-111
Created by admin on Sat Dec 16 16:20:01 GMT 2023 , Edited by admin on Sat Dec 16 16:20:01 GMT 2023
PRIMARY
DRUG BANK
DB12335
Created by admin on Sat Dec 16 16:20:01 GMT 2023 , Edited by admin on Sat Dec 16 16:20:01 GMT 2023
PRIMARY
EVMPD
SUB33975
Created by admin on Sat Dec 16 16:20:01 GMT 2023 , Edited by admin on Sat Dec 16 16:20:01 GMT 2023
PRIMARY
FDA UNII
EQL0E9GCX1
Created by admin on Sat Dec 16 16:20:01 GMT 2023 , Edited by admin on Sat Dec 16 16:20:01 GMT 2023
PRIMARY
WIKIPEDIA
TANEZUMAB
Created by admin on Sat Dec 16 16:20:01 GMT 2023 , Edited by admin on Sat Dec 16 16:20:01 GMT 2023
PRIMARY
ACTIVE MOIETY
TANEZUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966